FDAnews Drug Daily Bulletin

FDA Accepts Medarex Filing to Develop New Cancer Drug

Jan. 30, 2009
A A
Medarex Inc., a biopharmaceutical company … announced that the Food & Drug Administration has accepted its application for an investigational new drug to treat renal cell carcinoma and non-Hodgkin’s lymphoma.
NJBIZ